Lee Keng Siang, Siow Isabel, Zhang John Jy, Syn Nicholas L, Gillespie Conor S, Yuen Linus Zh, Anil Gopinathan, Yang Cunli, Chan Bernard Pl, Sharma Vijay Kumar, Teoh Hock-Luen, Mingxue Jing, Teo Kevin Soon Hwee, Myint May Zin, Bhogal Pervinder, Meyer Lukas, Schob Stefan, Sia Ching-Hui, Mpotsaris Anastasios, Maus Volker, Andersson Tommy, Arnberg Fabian, Gontu Vamsi Krishna, Lee Tsong-Hai, Tan Benjamin Y Q, Yeo Leonard Ll
Bristol Medical School, University of Bristol, Bristol, UK
Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
J Neurointerv Surg. 2023 Oct;15(10):1039-1045. doi: 10.1136/jnis-2022-019510. Epub 2022 Sep 29.
Mechanical thrombectomy (MT) is an effective treatment for patients with acute ischemic stroke (AIS) from basilar artery occlusion (BAO).
To compare the clinical outcomes of MT, with and without bridging intravenous thrombolysis (IVT), in acute BAO through a systematic review and meta-analysis of the current literature.
Systematic searches of Medline, EMBASE, and Cochrane Central were undertaken on August 1, 2022. Good functional outcome defined as 90-day modified Rankin Scale score 0-2 was the primary outcome measure. Secondary outcome measures were 90-day mortality, successful post-thrombectomy recanalization (modified Thrombolysis in Cerebral Infarction score ≥2b), symptomatic intracranial hemorrhage (sICH), and subarachnoid hemorrhage (SAH).
Three studies reporting 1096 patients with BAO AIS were included in the meta-analysis. No significant differences in good functional outcome were detected between the two groups (RR=1.28 (95% CI 0.86 to 1.92); p=0.117). However, specifically patients with large artery atherosclerosis (LAA) benefited from bridging IVT (OR=2.52 (95% CI 1.51 to 4.22); p<0.001) with better functional outcomes. There was a significantly lower 90-day mortality rate for patients who underwent bridging IVT compared with MT alone (RR=0.70 (95% CI 0.62 to 0.80); p=0.008). No significant differences were detected in rates of post-treatment recanalization (RR=1.01 (95% CI 0.35 to 2.91); p=0.954), sICH (RR=0.96 (95% CI 0.66 to 1.42); p=0.724), and SAH (RR=0.93 (95% CI 0.31 to 2.83); p=0.563).
In patients with AIS due to BAO, bridging IVT was associated with lower mortality rates at 90 days, compared with direct MT. There were no improved functional outcomes or increased sICH or SAH between both arms, However, patients with LAA benefited from bridging IVT, with better functional outcomes.
机械取栓术(MT)是治疗基底动脉闭塞(BAO)所致急性缺血性卒中(AIS)患者的有效方法。
通过对当前文献进行系统评价和荟萃分析,比较急性BAO患者接受MT联合或不联合静脉桥接溶栓(IVT)的临床结局。
于2022年8月1日对Medline、EMBASE和Cochrane Central进行系统检索。主要结局指标为功能良好结局,定义为90天改良Rankin量表评分为0 - 2分。次要结局指标为90天死亡率、血栓切除术后再通成功(改良脑梗死溶栓评分≥2b)、症状性颅内出血(sICH)和蛛网膜下腔出血(SAH)。
三项研究共纳入1096例BAO AIS患者进行荟萃分析。两组在功能良好结局方面未检测到显著差异(RR = 1.28(95%CI 0.86至1.92);p = 0.117)。然而,具体而言,大动脉粥样硬化(LAA)患者从静脉桥接溶栓中获益(OR = 2.52(95%CI 1.51至4.22);p < 0.001),功能结局更好。与单纯MT相比,接受静脉桥接溶栓的患者90天死亡率显著更低(RR = 0.70(95%CI 0.62至0.80);p = 0.008)。在治疗后再通率(RR = 1.01(95%CI 0.35至2.91);p = 0.954)、症状性颅内出血(RR = 0.96(95%CI 0.66至1.42);p = 0.724)和蛛网膜下腔出血(RR = 0.93(95%CI 0.31至2.83);p = 0.563)方面未检测到显著差异。
在BAO所致AIS患者中,与直接MT相比,静脉桥接溶栓与90天更低的死亡率相关。两组在功能结局改善、sICH或SAH增加方面均无差异。然而,LAA患者从静脉桥接溶栓中获益,功能结局更好。